Healthcare Equipment and Supplies
Company Overview of AccessClosure, Inc.
AccessClosure, Inc., a medical device company, designs, manufactures, and distributes access site management devices to address complex challenges in cardiovascular and peripheral vascular markets. The company offers MynxGrip Vascular Closure Device, an extravascular device that is used to seal femoral artery access sites; and Flash Ostial System Dual Balloon Angioplasty Catheter to help overcome the challenges of aorto-ostial stenting. It offers its products through its direct sales force in the United States; and a network of distributors internationally. The company was founded in 2002 and is based in Santa Clara, California. As of May 9, 2014, AccessClosure, Inc. operates as a subsidiary...
5452 Betsy Ross Drive
Santa Clara, CA 95054
Founded in 2002
Key Executives for AccessClosure, Inc.
Chief Executive Officer, President and Director
Vice President of Operations
Executive Vice President of Regulatory & Quality Affairs
Compensation as of Fiscal Year 2014.
AccessClosure, Inc. Key Developments
AccessClosure Inc. Launches Mynx Ace Vascular Closure Device
Mar 29 14
AccessClosure Inc. has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system1 to seal femoral artery access sites. The device joins the pioneering line of Mynx extravascular products that help care teams reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures. Mynx closure devices are designed for patient comfort by providing gentle vascular closure without the use of cinching, sutures, or metal implants to enhance patient satisfaction and keep physicians on patient care.2 With Mynx Ace, physicians can consistently close femoral artery access sites through a simple, three-step deployment system. The Mynx Ace system uses AccessClosure's proprietary Grip Technology, a major advancement in sealant technology. Grip Technology employs an extravascular sealant that actively adheres to the artery for safe and secure mechanical closure and dissolves within 30 days, leaving nothing behind in the healed vessel.
Federal Court Shuts Down Janzen Patent Infringement Claim Against AccessClosure, Inc
Dec 11 13
AccessClosure Inc. has announced that the U.S. Court of Appeals for the Federal Circuit denied a request by St. Jude Medical Inc. to rehear an appeal on a double patenting ruling concerning its U.S. Patent No. 7,008,439, covering technologies to close holes in arteries. The U.S. Court of Appeals' decision, holding the Janzen 439 patent invalid, supports the original jury verdict on Dec. 21, 2010 in the U.S. District Court for the Western District of Arkansas. The U.S. Court of Appeals will send the case back to the Texarkana District Court on December 16, 2013, when it issues its mandate.
AccessClosure, Inc. Announces Distribution Agreement with Ostial Corporation
Oct 8 13
AccessClosure, Inc. announced an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx(R) Product Family of Vascular Closure Devices to expand AccessClosure's portfolio. AccessClosure will showcase its growing portfolio of devices at booth 314 at the Vascular Interventional Advances 2013 (VIVA) this week in Las Vegas, NV, beginning when the exhibit hall opens at the Wynn Hotel.
Similar Private Companies By Industry
Recent Private Companies Transactions
April 2, 2014